UPDATED: FDA spurns hay fever drug from India's Glenmark

In its attempt to be transparent about manufacturing machinery, Indian drugmaker Glenmark appears to have shot itself in the foot with the FDA. On Saturday, the Maharashtra-based company disclosed that its hay fever drug, Ryaltris, had been rejected by the US health regulator.